返回ChemicalBook首页>CAS数据库列表>19916-73-5

19916-73-5

中文名称 O-6-苄基鸟嘌呤
英文名称 6-O-Benzylguanine
CAS 19916-73-5
分子式 C12H11N5O
MDL 编号 MFCD00269931
分子量 241.25
MOL 文件 19916-73-5.mol
更新日期 2024/04/23 09:50:13
19916-73-5 结构式 19916-73-5 结构式

基本信息

中文别名
2-氨基-6-(苄氧基)嘌呤
O-6-苄基鸟嘌呤
6-苄基鸟嘌呤
英文别名
2-Amino-6-(benzyloxy)purine
2-amino-6-(phenylmethoxy)-9h-purine
6-BENZYLOXY-9H-PURIN-2-AMINE
6-BENZYLOXY GUANINE
6-O-BENZYLGUANINE
O6-BENZYLGUANINE
4 6-Benzyloxyguanine
6-BENZYLOXY GUANINE2-AMINO-6-BENZYLOXYPURINE
O(sup 6)benzylguanidine
2-Amino-6-(benzyloxy)-9H-purine
6-(Benzyloxy)-1H-purin-2-amine

物理化学性质

外观性质白色粉末状固体。
熔点193(dec.)
沸点459.3±55.0 °C(Predicted)
密度1.48±0.1 g/cm3(Predicted)
储存条件room temp
溶解度methanol: 20 mg/mL
酸度系数(pKa)7.47±0.20(Predicted)
形态solid
颜色灰白色至淡黄色
检测方法HPLC

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H315-H319-H335
危险品标志Xi
危险类别码R36/37/38
安全说明S26-S36
WGK Germany3
Hazard NoteIrritant
海关编码29339900

应用领域

用途一
用于各种DNA修复机制研究。

常见问题列表

简介

O6-Benzylguanine 是鸟嘌呤类似物,是 DNA 修复酶 O6 烷基鸟嘌呤DNA烷基转移酶 (MGMT/AGT) 抑制剂。

药理活性
O6-Benzylguanine 作为 AGT 底物,将其苄基转移到 AGT 半胱氨酸残基上,从而不可逆地灭活 AGT 并阻止 DNA 修复。O6-Benzylguanine 诱导肿瘤细胞凋亡,具有抗肿瘤活性。
靶点
TargetValue
AGT
()
体外研究

The L3.6pl cells are relatively sensitive to O6-Benzylguanine (24-72 hours) in a dose- and time-dependent manner. The IC 50 is 50 μg (at 48 hours).
O6-Benzylguanine (50 μg; 48 hours) modulates p53 downstream target protein expression, induces apoptosis, and decreases cell proliferation.
O6-Benzylguanine (50 μg; 48 hours) significantly decreases the MGMT transcriptional activity in L3.6pl.

Western Blot Analysis

Cell Line: L3.6pl and PANC1 cells
Concentration: 50 μg
Incubation Time: 48 hours
Result: Expressions of O6 methyl guanine DNA methyl transferase (MGMT), cyclin B1, cyclin B2, cyclin A, p53, and ki-67 were decreased, whereas p21 was increased. The levels of cyto C and caspase 9 were increased, whereas the levels of PARP1 protein were decreased.

RT-PCR

Cell Line: L3.6pl cells
Concentration: 50 μg
Incubation Time: 48 hours
Result: Decreased the MGMT transcriptional activity in L3.6pl.
体内研究

O6-Benzylguanine (100 μg; i.p.; daily for 35 days) inhibits pancreatic cancer cell growth and increases pancreatic cell sensitivity to Gemcitabine (100 mg/kg).
O6-Benzylguanine inhibits pancreatic cancer cell proliferation and induces tumor cell apoptosis in vivo.

Animal Model: Male athymic nude mice (NCI-nu) (bearing human pancreatic cancer L3.6pl cells)
Dosage: 100 μg
Administration: i.p; daily for 35 days
Result: Significantly decreased median tumor volume and weight.

知名试剂公司产品信息

"19916-73-5" 相关产品信息
60-32-2 452-06-2 56-93-9 20535-83-5 100-44-7 591-27-5 77-86-1 1214-39-7 56-40-6 120-73-0 73-40-5 103-90-2 56-37-1 824-94-2 494-19-9 154-42-7 7051-34-5 57500-07-9